Replies to post #1092 on Vascular Biogenics Ltd (VBLT)

[Oren1976]

I emailed him about my prospect about avastin. Him and all 3 doctors involved in this trial. Of course no reply but I m sure they saw my emails. I also emailed fda - avastin shouldn't be given to rgbm patients

[gr8db8]

Notice the wording "a better planned randomized phase 2 BRAIN trial". You would think a company like Genentech/Roche have extensive experience in designing trials .... unless they intentionally designed the trial so that the data worked favorably for them. Seems like that strategy work for them ... billions for them and no improvement in mOS for the patients. This is all about greed and nothing to do with improving healthcare.

Biosimilars are taking their market share and hopefully VB-111 does too.